BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  AEON Biopharma Announces Strategic Reprioritization to Pursue a Biosimilar Pathway for ABP-450

  July 9, 2024

   · 

  6 min read
• Preveceutical Announces Revocation of Management Cease Trade Order

  July 9, 2024

   · 

  3 min read
• News

  Gain Therapeutics Announces the Completion of Dosing of the Phase 1 Study of GT-02287

  July 9, 2024

   · 

  6 min read
• News

  Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101

  July 9, 2024

   · 

  3 min read
• Drug Development

  Strong Proof-of-Concept Data from Phase 2 Trial of PDE10A Inhibitor (CPL’36), a Novel Oral Antipsychotic

  July 9, 2024

   · 

  9 min read
• Drug Development

  Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease

  July 9, 2024

   · 

  5 min read
• News

  VYNE Therapeutics Announces Appointment of Subhashis Banerjee, M.D.

  July 9, 2024

   · 

  6 min read
• FDA

  Elevar Therapeutics Reports Plans for Near-Term Resubmission of NDA for First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Following Type A FDA Meeting

  July 9, 2024

   · 

  6 min read
• Drug Development

  Arcutis Provides Update on sNDA for Roflumilast Cream 0.15% for Atopic Dermatitis

  July 9, 2024

   · 

  3 min read
• Business

  Bispecific Antibodies Market Regional Sales Antibodies Sales Market Forecast 2029

  July 9, 2024

   · 

  3 min read